Rhumbline Advisers Anika Therapeutics, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 22,356 shares of ANIK stock, worth $367,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,356
Previous 24,231 7.74%
Holding current value
$367,979
Previous $613,000 9.95%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$24.25 - $28.75 $45,468 - $53,906
-1,875 Reduced 7.74%
22,356 $552,000
Q2 2024

Aug 01, 2024
SELL
$24.57 - $28.47 $417 - $483
-17 Reduced 0.07%
24,231 $613,000
Q1 2024

May 09, 2024
SELL
$21.95 - $26.42 $20,874 - $25,125
-951 Reduced 3.77%
24,248 $615,000
Q4 2023

Feb 08, 2024
SELL
$18.47 - $23.3 $15,367 - $19,385
-832 Reduced 3.2%
25,199 $571,000
Q3 2023

Nov 09, 2023
SELL
$16.98 - $26.1 $436,080 - $670,300
-25,682 Reduced 49.66%
26,031 $484,000
Q2 2023

Aug 08, 2023
BUY
$25.16 - $28.86 $60,157 - $69,004
2,391 Added 4.85%
51,713 $1.34 Million
Q1 2023

May 11, 2023
BUY
$25.91 - $32.1 $90,607 - $112,253
3,497 Added 7.63%
49,322 $1.42 Million
Q4 2022

Feb 14, 2023
BUY
$23.85 - $31.91 $12,115 - $16,210
508 Added 1.12%
45,825 $1.36 Million
Q3 2022

Nov 10, 2022
BUY
$21.74 - $24.68 $32,653 - $37,069
1,502 Added 3.43%
45,317 $1.08 Million
Q2 2022

Aug 11, 2022
BUY
$20.4 - $25.53 $15,483 - $19,377
759 Added 1.76%
43,815 $978,000
Q1 2022

May 12, 2022
BUY
$24.7 - $36.54 $25,021 - $37,015
1,013 Added 2.41%
43,056 $1.08 Million
Q4 2021

Feb 10, 2022
SELL
$35.83 - $45.03 $10,999 - $13,824
-307 Reduced 0.72%
42,043 $1.51 Million
Q3 2021

Nov 12, 2021
SELL
$38.75 - $44.47 $173,367 - $198,958
-4,474 Reduced 9.55%
42,350 $1.8 Million
Q2 2021

Aug 05, 2021
SELL
$39.42 - $48.08 $153,816 - $187,608
-3,902 Reduced 7.69%
46,824 $2.03 Million
Q1 2021

May 06, 2021
BUY
$32.49 - $45.96 $70,860 - $100,238
2,181 Added 4.49%
50,726 $2.07 Million
Q4 2020

Feb 10, 2021
BUY
$32.59 - $45.26 $158,191 - $219,692
4,854 Added 11.11%
48,545 $2.2 Million
Q3 2020

Nov 12, 2020
SELL
$32.56 - $38.57 $94,196 - $111,583
-2,893 Reduced 6.21%
43,691 $1.55 Million
Q2 2020

Aug 13, 2020
SELL
$27.83 - $37.73 $99,130 - $134,394
-3,562 Reduced 7.1%
46,584 $1.76 Million
Q1 2020

May 06, 2020
BUY
$22.38 - $54.06 $56,106 - $135,528
2,507 Added 5.26%
50,146 $1.45 Million
Q4 2019

Feb 05, 2020
BUY
$51.85 - $73.36 $142,898 - $202,180
2,756 Added 6.14%
47,639 $2.47 Million
Q3 2019

Oct 23, 2019
BUY
$40.05 - $57.47 $70,688 - $101,434
1,765 Added 4.09%
44,883 $2.46 Million
Q2 2019

Aug 14, 2019
BUY
$30.3 - $41.14 $17,574 - $23,861
580 Added 1.36%
43,118 $1.75 Million
Q1 2019

May 01, 2019
BUY
$29.37 - $40.49 $10,749 - $14,819
366 Added 0.87%
42,538 $1.29 Million
Q4 2018

Jan 31, 2019
BUY
$30.16 - $43.0 $183,372 - $261,440
6,080 Added 16.85%
42,172 $1.42 Million
Q3 2018

Nov 07, 2018
BUY
$32.83 - $42.51 $8,010 - $10,372
244 Added 0.68%
36,092 $1.52 Million
Q2 2018

Aug 06, 2018
BUY
$28.77 - $48.27 $56,734 - $95,188
1,972 Added 5.82%
35,848 $1.15 Million
Q1 2018

May 02, 2018
BUY
$49.22 - $68.43 $34,207 - $47,558
695 Added 2.09%
33,876 $1.68 Million
Q4 2017

Feb 09, 2018
BUY
$52.14 - $59.94 $252,149 - $289,869
4,836 Added 17.06%
33,181 $1.79 Million
Q3 2017

Nov 06, 2017
BUY
$51.16 - $58.21 $1.45 Million - $1.65 Million
28,345
28,345 $1.64 Million

Others Institutions Holding ANIK

# of Institutions
123
Shares Held
11.5M
Call Options Held
200
Put Options Held
100
View Full List

About Anika Therapeutics, Inc.

ANIK Quotes by TradingView
  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $240M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email